{
    "xml": "<topic id=\"PHP34479\" outputclass=\"drug\" rev=\"1.12\" type=\"drug\" namespace=\"/drugs/dolutegravir\" basename=\"dolutegravir\" title=\"DOLUTEGRAVIR\">\n<title>DOLUTEGRAVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1289\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\">Dolutegravir</xref>\n</p>\n<data name=\"vtmid\">23942511000001102</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_432836609\" title=\"HIV-integrase inhibitors\">HIV-integrase inhibitors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP56897\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/dolutegravir\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dolutegravir is an inhibitor of HIV integrase.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56868\" outputclass=\"indicationsAndDose\" rev=\"1.43\" parent=\"/drugs/dolutegravir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection without resistance to other inhibitors of HIV integrase, in combination with other antiretroviral drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg once daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in patients where resistance to other inhibitors of HIV integrase suspected, in combination with other antiretroviral drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg twice daily, dose to be taken with food.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection in combination with other antiretroviral drugs (with concomitant efavirenz, nevirapine, tipranavir, or rifampicin)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8239;mg twice daily, avoid concomitant use with these drugs if resistance to other inhibitors of HIV integrase suspected.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56856\" outputclass=\"interactions\" rev=\"1.21\" parent=\"/drugs/dolutegravir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (dolutegravir).</p>\n<p>Caution&#8212;avoid concomitant use with etravirine, unless used in combination with atazanavir, darunavir, or lopinavir.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56780\" outputclass=\"sideEffects\" rev=\"1.14\" parent=\"/drugs/dolutegravir\">\n<title>Side-effects</title>\n<body>\r\n<section outputclass=\"generalSideEffects\">\r\n<sectiondiv outputclass=\"frequencies\">\r\n<sectiondiv outputclass=\"commonOrVeryCommon\">\r\n<p outputclass=\"title\">Common or very common</p>\r\n<p outputclass=\"sideEffects\">\r\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">abnormal dreams</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">fatigue</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">raised creatine kinase</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\r\n</p>\n</sectiondiv>\r\n<sectiondiv outputclass=\"uncommon\">\r\n<p outputclass=\"title\">Uncommon</p>\r\n<p outputclass=\"sideEffects\">\r\n<ph outputclass=\"sideEffect\">Hepatitis</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>\r\n</p>\n</sectiondiv>\r\n\r\n\r\n<sectiondiv outputclass=\"notKnown\">\r\n<p outputclass=\"title\">Frequency not known</p>\r\n<p outputclass=\"sideEffects\">\r\n<ph outputclass=\"sideEffect\">Osteonecrosis</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n<section outputclass=\"sideEffectsAdvice\">\r\n<title>Side-effects, further information</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Hypersensitivity reactions</p>\r\n<p>Hypersensitivity reactions (including severe rash, or rash accompanied by fever, malaise, arthralgia, myalgia, blistering, oral lesions, conjunctivitis, angioedema, eosinophilia, or raised liver enzymes) reported uncommonly. Discontinue immediately if any sign or symptoms of hypersensitivity reactions develop.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Osteonecrosis</p>\r\n<p>For further information see <xref format=\"dita\" href=\"#PHP78275\" type=\"bookmark\" namespace=\"/treatment-summaries/hiv-infection\">HIV infection</xref>.</p>\n</sectiondiv>\n</section>\r\n\r\n</body>\n</topic>\n<topic id=\"PHP56837\" outputclass=\"pregnancy\" parent=\"/drugs/dolutegravir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56883\" outputclass=\"hepaticImpairment\" parent=\"/drugs/dolutegravir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56985\" outputclass=\"directionsForAdministration\" rev=\"1.14\" parent=\"/drugs/dolutegravir\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid antacids 6 hours before or 2 hours after taking dolutegravir.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56831\" outputclass=\"patientAndCarerAdvice\" rev=\"1.12\" parent=\"/drugs/dolutegravir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundMissedDoses\">\n<title>Missed doses</title>\n<sectiondiv>\n<p>If a dose is more than 20 hours late on the once daily regimen (or more than 8 hours late on the twice daily regimen), the missed dose should not be taken and the next dose should be taken at the normal time.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer dolutegravir tablets.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34479-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/dolutegravir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94213\" title=\"Tablet\" namespace=\"/drugs/dolutegravir/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP106633\" namespace=\"/drugs/abacavir-with-dolutegravir-and-lamivudine\" title=\"ABACAVIR WITH DOLUTEGRAVIR AND LAMIVUDINE\" count=\"1\" rel=\"backlink\">ABACAVIR WITH DOLUTEGRAVIR AND LAMIVUDINE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e74408\" href=\"#bnf_d1e74408\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tipranavir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e74408</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1055\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tipranavir\" title=\"Tipranavir\" count=\"1\" rel=\"backlink\">Tipranavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e72146\" href=\"#bnf_d1e72146\" namespace=\"/interactions/list-of-drug-interactions/antivirals/etravirine\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e72146</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1135\" namespace=\"/interactions/list-of-drug-interactions/antivirals/etravirine\" title=\"Etravirine\" count=\"1\" rel=\"backlink\">Etravirine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69164\" href=\"#bnf_d1e69164\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69164</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69191\" href=\"#bnf_d1e69191\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69191</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69287\" href=\"#bnf_d1e69287\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69287</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69367\" href=\"#bnf_d1e69367\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69367</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e69407\" href=\"#bnf_d1e69407\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e69407</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e23696\" href=\"#bnf_d1e23696\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e23696</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_201\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/rifamycins/rifampicin\" title=\"Rifampicin\" count=\"1\" rel=\"backlink\">Rifampicin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e78925\" href=\"#bnf_d1e78925\" namespace=\"/interactions/list-of-drug-interactions/antivirals/nevirapine\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e78925</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_843\" namespace=\"/interactions/list-of-drug-interactions/antivirals/nevirapine\" title=\"Nevirapine\" count=\"1\" rel=\"backlink\">Nevirapine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#bnf_d1e76668\" href=\"#bnf_d1e76668\" namespace=\"/interactions/list-of-drug-interactions/antivirals/efavirenz\" title=\"\" count=\"1\" rel=\"backlink\">bnf_d1e76668</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_874\" namespace=\"/interactions/list-of-drug-interactions/antivirals/efavirenz\" title=\"Efavirenz\" count=\"1\" rel=\"backlink\">Efavirenz</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1289\" namespace=\"/interactions/list-of-drug-interactions/antivirals/dolutegravir\" title=\"Dolutegravir\" count=\"1\" rel=\"link\">Dolutegravir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"1\" rel=\"link\">HIV infection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP94213\" namespace=\"/drugs/dolutegravir/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP34479",
    "outputclass": "drug",
    "rev": "1.12",
    "type": "drug",
    "namespace": "/drugs/dolutegravir",
    "basename": "dolutegravir",
    "title": "DOLUTEGRAVIR",
    "interactants": [
        {
            "id": "bnf_int_1289",
            "label": "Dolutegravir"
        }
    ],
    "vtmid": "23942511000001102",
    "drugClassification": [
        "HIV-integrase inhibitors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Dolutegravir is an inhibitor of HIV integrase.",
                "html": "<p>Dolutegravir is an inhibitor of HIV integrase.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection without resistance to other inhibitors of HIV integrase, in combination with other antiretroviral drugs",
                        "html": "HIV infection without resistance to other inhibitors of HIV integrase, in combination with other antiretroviral drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50 mg once daily.",
                        "html": "<p>50&#8239;mg once daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "HIV infection in patients where resistance to other inhibitors of HIV integrase suspected, in combination with other antiretroviral drugs",
                        "html": "HIV infection in patients where resistance to other inhibitors of HIV integrase suspected, in combination with other antiretroviral drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50 mg twice daily, dose to be taken with food.",
                        "html": "<p>50&#8239;mg twice daily, dose to be taken with food.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "HIV infection in combination with other antiretroviral drugs (with concomitant efavirenz, nevirapine, tipranavir, or rifampicin)",
                        "html": "HIV infection in combination with other antiretroviral drugs (with concomitant efavirenz, nevirapine, tipranavir, or rifampicin)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "50 mg twice daily, avoid concomitant use with these drugs if resistance to other inhibitors of HIV integrase suspected.",
                        "html": "<p>50&#8239;mg twice daily, avoid concomitant use with these drugs if resistance to other inhibitors of HIV integrase suspected.</p>"
                    }
                ]
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (dolutegravir).\n\nCaution&#8212;avoid concomitant use with etravirine, unless used in combination with atazanavir, darunavir, or lopinavir.",
                "html": "<p>Appendix 1 (dolutegravir).</p><p>Caution&#8212;avoid concomitant use with etravirine, unless used in combination with atazanavir, darunavir, or lopinavir.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "abnormal dreams",
                        "html": "abnormal dreams",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fatigue",
                        "html": "fatigue",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "raised creatine kinase",
                        "html": "raised creatine kinase",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Hepatitis",
                        "html": "Hepatitis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Osteonecrosis",
                        "html": "Osteonecrosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hypersensitivity reactions",
                "textContent": "Hypersensitivity reactions (including severe rash, or rash accompanied by fever, malaise, arthralgia, myalgia, blistering, oral lesions, conjunctivitis, angioedema, eosinophilia, or raised liver enzymes) reported uncommonly. Discontinue immediately if any sign or symptoms of hypersensitivity reactions develop.",
                "html": "<p>Hypersensitivity reactions (including severe rash, or rash accompanied by fever, malaise, arthralgia, myalgia, blistering, oral lesions, conjunctivitis, angioedema, eosinophilia, or raised liver enzymes) reported uncommonly. Discontinue immediately if any sign or symptoms of hypersensitivity reactions develop.</p>"
            },
            {
                "type": "advice",
                "references": [
                    {
                        "id": "PHP78275",
                        "label": "HIV infection"
                    }
                ],
                "title": "Osteonecrosis",
                "textContent": "For further information see HIV infection.",
                "html": "<p>For further information see <xref format=\"dita\" href=\"#PHP78275\" type=\"bookmark\" namespace=\"/treatment-summaries/hiv-infection\">HIV infection</xref>.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in severe impairment&#8212;no information available.",
                "html": "<p>Manufacturer advises caution in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Avoid antacids 6 hours before or 2 hours after taking dolutegravir.",
                "html": "<p>Avoid antacids 6 hours before or 2 hours after taking dolutegravir.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundMissedDoses": [
            {
                "type": "adviceAroundMissedDoses",
                "textContent": "If a dose is more than 20 hours late on the once daily regimen (or more than 8 hours late on the twice daily regimen), the missed dose should not be taken and the next dose should be taken at the normal time.",
                "html": "<p>If a dose is more than 20 hours late on the once daily regimen (or more than 8 hours late on the twice daily regimen), the missed dose should not be taken and the next dose should be taken at the normal time.</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer dolutegravir tablets.",
                "html": "<p>Patients or carers should be given advice on how to administer dolutegravir tablets.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP94213",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP106633",
                "label": "ABACAVIR WITH DOLUTEGRAVIR AND LAMIVUDINE",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "#bnf_d1e74408": [
            {
                "id": "bnf_d1e74408",
                "label": "bnf_d1e74408",
                "type": "#bnf_d1e74408"
            }
        ],
        "interaction": [
            {
                "id": "bnf_int_1055",
                "label": "Tipranavir",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1135",
                "label": "Etravirine",
                "type": "interaction"
            },
            {
                "id": "bnf_int_201",
                "label": "Rifampicin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_843",
                "label": "Nevirapine",
                "type": "interaction"
            },
            {
                "id": "bnf_int_874",
                "label": "Efavirenz",
                "type": "interaction"
            }
        ],
        "#bnf_d1e72146": [
            {
                "id": "bnf_d1e72146",
                "label": "bnf_d1e72146",
                "type": "#bnf_d1e72146"
            }
        ],
        "#bnf_d1e69164": [
            {
                "id": "bnf_d1e69164",
                "label": "bnf_d1e69164",
                "type": "#bnf_d1e69164"
            }
        ],
        "#bnf_d1e69191": [
            {
                "id": "bnf_d1e69191",
                "label": "bnf_d1e69191",
                "type": "#bnf_d1e69191"
            }
        ],
        "#bnf_d1e69287": [
            {
                "id": "bnf_d1e69287",
                "label": "bnf_d1e69287",
                "type": "#bnf_d1e69287"
            }
        ],
        "#bnf_d1e69367": [
            {
                "id": "bnf_d1e69367",
                "label": "bnf_d1e69367",
                "type": "#bnf_d1e69367"
            }
        ],
        "#bnf_d1e69407": [
            {
                "id": "bnf_d1e69407",
                "label": "bnf_d1e69407",
                "type": "#bnf_d1e69407"
            }
        ],
        "#bnf_d1e23696": [
            {
                "id": "bnf_d1e23696",
                "label": "bnf_d1e23696",
                "type": "#bnf_d1e23696"
            }
        ],
        "#bnf_d1e78925": [
            {
                "id": "bnf_d1e78925",
                "label": "bnf_d1e78925",
                "type": "#bnf_d1e78925"
            }
        ],
        "#bnf_d1e76668": [
            {
                "id": "bnf_d1e76668",
                "label": "bnf_d1e76668",
                "type": "#bnf_d1e76668"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1289",
                "label": "Dolutegravir",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP94213",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}